Literature DB >> 24829697

Blue Rubber Bleb Nevus Syndrome as a rare Cause of Iron Deficiency Anemia: a Case Report and Review of Literature.

Mohammad Javad Zahedi1, Sodaif Darvish Moghadam1, Seyed Mahdi Seyed Mirzaei1, Masood Dehghani2, Sara Shafiei Pour1, Atefe Rasti2.   

Abstract

Blue Rubber Bleb Nevus Syndrome is a rare disorder that is characterizedby multiple recurrent vascular malformations of skin and gastrointestinal tract.The affected patients may present with diverse manifestations including irondeficiency anemia. We report this syndrome in a 22-year-old man that was referred to our hospitalfor iron deficiency anemia with unknown cause and vascular malformationsin the skin and gastrointestinal tract. Because of stable hemoglobin level,we decided to treatment him by iron supplementation and close follow up. Wereport this case along with a review of literature.

Entities:  

Keywords:  Blue rubber bleb nevus syndrome; Iron deficiencyAnemia; Vascular malformations

Year:  2013        PMID: 24829697      PMCID: PMC3990150     

Source DB:  PubMed          Journal:  Middle East J Dig Dis        ISSN: 2008-5230


INTRODUCTION

Blue Rubber Bleb Nevus Syndrome (BRBNS) or Bean’s syndrome is a disorder characterized by distinctive vascular malformations that mostly involve cutaneous and gastrointestinal tract .[1]Occult bleeding and iron deficiency anemia (IDA) are the most common clinical presentation of BRBNS but melena ,hematochezia and involvement of internal organs has also been reported.[1, 2]It is a very rare syndrome and only about 200 cases have been reported till 2012. Here, we report a case of BRBNS that present with IDA. To the best of our knowledge this is the second case reported from Iran.[3]

CASE REPORT

A 22 years old man was referred to the GI clinic of Afzalpour Hospital for evaluation of IDA. There was no history of frank bleeding including melena, hematemesis or rectal bleeding. History of abdominal pain, prolonged diarrhea and/or constipation, vomiting, flatulence and prolonged fever were negative. Drug history was negative including for non–steroidal anti- inflammatory agents. He has been receiving occasionally intravenous iron during the last three years. He suffered from a vascular mass on right supraclavicular region at birth with gradual enlargement. At the childhood, surgical resection of the mass was performed and histology showed irregular cavernous channels in both cutaneous and subcutaneous tissue compatible with venous malformation. At the age of 15, oral iron intake was started because of IDA. At about the same time, multiple bluish colored nodular lesions appeared on his lower extremities. Familial history was negative for vascular lesions resembling BRBNS and any other remarkable diseases. He was not drug abuser and drug history included only oral and intravenous iron supplementation since 7 years ago. In physical examination he appeared well nourished but pale. Multiple compressible bluish nodules on lower extremities were seen (Figure1). These nodules measured from 0.5 to 1.5 cm and tended to refill after compression. Scar of a previous incision was present on the right supraclavicular region (Figure2). Otherwise, the physical examination was unremarkable.
Fig.1
Fig.2
Multiple compressible bluish nodules on the patient foot. Scar of previous surgical incision on the right supraclavicular region. Laboratory findings revealed a hemoglobin level of 10.5 g/dL. Other lab results are shown in table 1. The results of routine laboratory tests were within normal limits. Upper and lower gastrointestinal endoscopy along with duodenal biopsy had been performed 4 years ago and was normal.Serum immunoglobulin A(Ig A) and anti-tissue transglutaminase antibody (TTG) -Ig A levels were also normal.
Table 1

Results of patient laboratory tests on admission

Variable Reference Range, Age-Adjusted On admission
White-cell count (per mm3) 4000–11,0006500
Hematocrit (%)Hemoglobin (g/dl)MCV (μm[3])MCH (pg)MCHC (g/dL) 38-4614–16.5 (men)89-9827-3032-35 31.710.5752025.7
Platelet count (per mm3) 150000-450000230000
Ferittin( µg/dl) 30-25010
Creatinine (mg/dl) 0.5 -10.8
Albumin(g/dl) 3.5-4.54
Lactate dehydrogenase(U/liter) 150-230210
Erythrocyte sedimentation rate (mm/hr) Less than 2012
Anti-tissue transglutaminase antibody(Ig A) IU/ml Under 10Neg
Prothrombin time (sec) 12-1314
International normalized ratio for prothrombin time 12-131.2
Alanine aminotransferase(U/liter) 18-3422
Aspartate aminotransferase(U/liter) 12-3018
Alkaline phosphatase(U/liter 68-24088
In our center the patient underwent upper and lower GI endoscopy for second time. In upper endoscopy, a bluish vascular lesion with 10 mm diameter and wrinkled surface was seen in proximal part of duodenum (Figure3-a).Colonoscopy also revealed a similar lesion in the descending part of colon (Figure3-b). The patient refused assessment of the small intestine tract.

Fig. (3-a, 3 -b)

3-a (left) shows a bluish vascular lesion with wrinkled surface in proximal part of duodenum. 3-b (Right) a similar lesion in the descending part of colon.

DISCUSSION

Important diseases that involve the skin and gastrointestinal tract with vascular malformations include BRBNS, Mafucci’s syndrome and Osler-Weber- Rendu syndrome. However, Rendu-Osler-Weber syndrome is an inherited autosomal dominant condition and these patients often experience recurrent episodes of epistaxis with telangiectasia in histologic examination [4] and patients with Mafucci’s syndrome also have bone malformations and chondrodysplasias.[5] A diagnosis of BRBNS was made on the basis of the typical skin lesions which were rubbery discrete compressible blebs increasing in number over the years, multiple bluish nevi in duodenum and colon on GI endoscopy, and histological picture of venous malformation on skin biopsy.[1-3,6-7], Therefore, we were able to diagnose our patient with BRBNS. BRBNS (or Bean’s syndrome) is a rare disorder that is characterized by multiple recurrent vascular malformations that primarily involve the skin and the gastrointestinal tract .[1]The disease and its association with hemagniomas in the skin and gastrointestinal tract was first reported in 1860 by Gascoyen.[8]A century later in 1958, William Bean named it as BRBNS.[9] Skin lesions in BRBNS are often first noticed at birth or in the neonatal period, but can present later .[7]The size ranges from a few millimeters to many centimeters. Lesions mainly appear in the trunk and upper extremities. Three types of skin lesions have been described .[3]The most common type is red to blue, nipple-like skin lesion that is easily compressible and refills slowly on release of pressure. This is an important diagnostic sign .[8]The skin lesions in this case were also small, bluish, soft and compressible, and they occurred in the upper and lower extremities; these are the typical features of BRBNS. The gastrointestinal tract is the most common organ involved in this disorder, small bowel and distal colon are predominantly affected .[9] Bleeding from vascular malformations in gasterointestinal tract often cause IDA that is the most common clinical manifestation of BRBNS but rarely presented as melena or hematochezia.[1, 2] In endoscopy, the mucosal nodules are either flat, polypoid or have central bluish nipples.[1, 7] In our case, the gastrointestinal lesions were limited to two protuberant lesions with wrinkled surface in duodenum and distal part of colon. Rarely, involvement of other internal organs occurs and can result in hemothorax, hemopericardium, pulmonary hypertension and central nervous system symptoms.[10-12] Often, BRBNS develops sporadically, but sometimes is inherited as an autosomal dominant pattern and its association with chromosome 9p has already been established .[13]Our case seems to have developed sporadically because no family member had history of BRBNS. In most cases,only asymptomatic skin lesions are present and patients have a normal life span without any malignant transformation. Extent of visceral organ involvement determines the prognosis of disease. GI bleeding and rarely, central nervous system involvement can befatal and skeletal lesions are able to cause functional and physical inability.[12] Intussusceptions, volvulus, and bowel infarction should be considered in patient with BRBNS and abdominal pain.[14] The treatment of BRBNS is mainly conservative. When the patient is asymptomatic and only has mild anemia, observation and iron supplements are adequate.[1- 3] Several therapeutic modalities have been attempted to date for treating BRBNS. Antiangiogenetic agents such as steroids, interferon α-2a and octreotide have been applied to reduce the frequency and severity of bleeding episodes.[15,16]Unfortunately, in most cases, discontinuing administration of these medical treatments has led to recurrence of the disease .[15,17] Although endoscopic laser photocoagulation, sclerosis, band ligation and polypectomy have been successfully utilized, they may be dangerous in transmural lesions.[18,19] Laparatomy with intraoperative endoscopy may be the best approach for patients with refractory anemia and multiple lesions in GI tract especially small bowel.[15- 20]In the largest study on treatment of BRBNS published so far, ten patients with BRBNS and IDA with prior history of at least one blood transfusion, underwent whole GI endoscopy. All GI lesions were removed and patients were followed for five years. Subsequent gastrointestinal bleeding recurred in only one patient who had received less extensive procedures.[20] Our patient was consulted about the natural history of the disease and the chronicity of the condition which is disabling but not fatal in majority of cases. He was discharged on iron supplements. He did well during 2 years of follow up and his hemoglobin level was maintained without any need to transfusions. Long term follow up is required to evaluate the effect of conservative treatment with iron supplementation in this patient and determine surgical intervention will be necessary or not.

CONFLICT OF INTEREST

The authors declare no conflict of interest related to this work.
  17 in total

Review 1.  Blue rubber bleb nevus syndrome causing upper GI hemorrhage: a novel management approach and review.

Authors:  Manisha Dwivedi; Sri Prakash Misra
Journal:  Gastrointest Endosc       Date:  2002-06       Impact factor: 9.427

Review 2.  Blue rubber bleb nevus syndrome: gastrointestinal involvement and its endoscopic presentation.

Authors:  S H Gallo; S A McClave
Journal:  Gastrointest Endosc       Date:  1992 Jan-Feb       Impact factor: 9.427

3.  Blue rubber bleb nevus syndrome.

Authors:  Paul L Beck; Alexander I Aspinall; Vivan M Kilvert; Joseph Dort
Journal:  Gastrointest Endosc       Date:  2002-10       Impact factor: 9.427

4.  Blue rubber bleb nevus syndrome: treatment of multiple gastrointestinal hemangiomas with argon plasma coagulator.

Authors:  Enders K W Ng; Frances K Y Cheung; Philip W Y Chiu
Journal:  Dig Endosc       Date:  2009-01       Impact factor: 7.559

5.  Blue rubber bleb nevus syndrome: surgical eradication of gastrointestinal bleeding.

Authors:  Steven J Fishman; C Jason Smithers; Judah Folkman; Dennis P Lund; Patricia E Burrows; John B Mulliken; Victor L Fox
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

6.  Hemothorax and hemopericardium in a patient with Bean's blue rubber bleb nevus syndrome.

Authors:  D Langleben; N Wolkove; H Srolovitz; R C Billick; N M Sheiner
Journal:  Chest       Date:  1989-06       Impact factor: 9.410

7.  Blue rubber bleb nevus (Bean syndrome): evolution of four cases and clinical response to pharmacologic agents.

Authors:  M D Boente; M R Cordisco; M D Frontini; R A Asial
Journal:  Pediatr Dermatol       Date:  1999 May-Jun       Impact factor: 1.588

8.  Chronic subcutaneous octreotide decreases gastrointestinal blood loss in blue rubber-bleb nevus syndrome.

Authors:  D Gonzalez; B J Elizondo; S Haslag; G Buchanan; J S Burdick; P C Guzzetta; B A Hicks; J M Andersen
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001-08       Impact factor: 2.839

9.  Severe blue rubber bleb nevus syndrome in a neonate.

Authors:  L F Hansen; V Wewer; S A Pedersen; P Matzen; A Paerregaard
Journal:  Eur J Pediatr Surg       Date:  2008-07-15       Impact factor: 2.191

10.  A gene for familial venous malformations maps to chromosome 9p in a second large kindred.

Authors:  C J Gallione; K A Pasyk; L M Boon; F Lennon; D W Johnson; E A Helmbold; D S Markel; M Vikkula; J B Mulliken; M L Warman
Journal:  J Med Genet       Date:  1995-03       Impact factor: 6.318

View more
  7 in total

1.  [Bean's syndrome in children: about two cases].

Authors:  Achraf El Bakkaly; Fouad Ettayebi; Houda Oubeja; Mounir Erraji; Hicham Zerhouni
Journal:  Pan Afr Med J       Date:  2017-10-04

2.  Blue Rubber Bleb Nevus Syndrome in a Child.

Authors:  Sahana M Srinivas; R Premalatha
Journal:  J Clin Diagn Res       Date:  2015-07-01

3.  Bean Syndrome in a Child Treated with Sirolimus: About a Case.

Authors:  Ayad Ghanam; Aziza Elouali; Merouane Nour; Maria Rkain; Noufissa Benajiba; Abdeladim Babakhouya
Journal:  Case Rep Pediatr       Date:  2022-05-24

Review 4.  [Clinical effect of sirolimus in treatment of blue rubber bleb nevus syndrome in children: a report of 2 cases and literature review].

Authors:  Xu Quan; Chun-Di Xu; Ping Liu; Qing-Qing Zhang; Ye Chen; Le Wang; Yuan Xiao
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-09

5.  An atypical presentation of blue rubber bleb nevus syndrome.

Authors:  Jessica Gonzalez-Hernandez; Luis Lizardo-Sanchez
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-07

Review 6.  Role of octreotide in small bowel bleeding.

Authors:  Anwar Khedr; Esraa Elaraby Mahmoud; Noura Attallah; Mikael Mir; Sydney Boike; Ibtisam Rauf; Abbas B Jama; Hisham Mushtaq; Salim Surani; Syed A Khan
Journal:  World J Clin Cases       Date:  2022-09-16       Impact factor: 1.534

7.  Subconjunctival Hemorrhage in a Child with the Blue Rubber Bleb Nevus Syndrome on Treatment with Oral Propranolol.

Authors:  Karen De Loecker; Veerle Labarque; Hilde Seynaeve; Ingele Casteels
Journal:  Case Rep Ophthalmol       Date:  2021-05-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.